Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency

Inclusion Criteria: * \- Patients must be 18 years or older as well as willing and able to provide informed consent * Patients undergoing a scheduled gynecologic procedure with cystoscopy Exclusion Criteria: * \- Patients are younger than 18 years * Patients are unable or unwilling to provide informed consent * Patients with a history of an allergic reaction to sodium fluorescein or phenazopyridine * Patients with a history of renal insufficiency * Patients with a history of liver disease * Patients with a history of sickle cell disease * Patients with a history of glucose-6-phosphate dehydrogenase deficiency * Patients with a history of chronic obstructive pulmonary disease or currently being treated for asthma